A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation

Nevens, F; Gustot, T; Laterre, PF; Lasser, LL; Haralampiev, LE; Vargas, V; Lyubomirova, D; Albillos, A; Najimi, M; Michel, S; Stoykov, I; Gordillo, N; Vainilovich, Y; Barthel, V; Clerget-Chossat, N; Sokal, EM

Sokal, EM (corresponding author), Promethera Biosci, Watson & Crick Hill,Rue Granbonpre 11, B-1435 Mont St Guibert, Belgium.

JHEP REPORTS, 2021; 3 (4):

Abstract

Background & Aims: Human allogeneic liver-derived progenitor cells (HALPC, HepaStem (R); Promethera Biosciences, MontSaint-Guibert, Belgium) are a......

Full Text Link